TABLE 1

Mean Liver SUV in Syngeneic, Allogeneic, and Tacrolimus-Treated Allogeneic Hepatic Transplantation Rats

Rat no.Day 2Day 3Days 5–6Days 8–9Day of sacrifice
Syngeneic0.61 ± 0.11*0.61 ± 0.13*0.73 ± 0.21*0.77 ± 0.17*
 10.51 ± 0.130.47 ± 0.010.81 ± 0.018
 20.70 ± 0.050.61 ± 0.080.58 ± 0.035
 30.63 ± 0.04Missing data3
 40.61 ± 0.190.68 ± 0.030.68 ± 0.069
 50.94 ± 0.020.99 ± 0.118
 60.96 ± 0.110.58 ± 0.099
Allogeneic0.98 ± 0.231.55 ± 0.573.18 ± 0.805.08 ± 1.18
 10.99 ± 0.282.72 ± 0.064.04 ± 0.248
 21.17 ± 0.041.33 ± 0.103.34 ± 0.455
 30.76 ± 0.091.18 ± 0.033
 42.17 ± 0.664.51 ± 0.245.63 ± 1.649
 52.97 ± 0.345.33 ± 1.348
 62.38 ± 0.135.32 ± 0.909
Allogeneic + tacrolimus, days 0–80.81 ± 0.160.98 ± 0.10*0.73 ± 0.09*
 10.84 ± 0.101.04 ± 0.070.64 ± 0.019
 20.64 ± 0.040.97 ± 0.150.76 ± 0.069
 30.96 ± 0.120.93 ± 0.050.78 ± 0.099
Allogeneic + tacrolimus, days 2–80.87 ± 0.080.91 ± 0.18*0.91 ± 0.11*
 10.87 ± 0.050.92 ± 0.061.03 ± 0.029
 20.90 ± 0.071.11 ± 0.050.91 ± 0.009
 30.84 ± 0.130.71 ± 0.050.78 ± 0.039
  • * P < 0.01, vs. untreated allogeneic transplantation rats at each time point.

  • Because of scanner malfunction.

  • P < 0.05, vs. syngeneic transplantation rats at each time point.

  • Data represent mean ± SD in groups or individuals.